OrthoPediatrics director receives stock award

OrthoPediatrics Corp director Bryan W. Hughes received a stock award of 11,436 shares of common stock.

Rhea-AI Filing Summary

OrthoPediatrics Corp director Bryan W. Hughes received a stock award of 11,436 shares of common stock. The shares were granted at no cash cost as equity compensation, rather than bought on the open market. After this award, his direct holdings total 32,663 shares.

A footnote explains that these holdings include restricted stock awards totaling 17,959 shares, which typically vest over time subject to conditions. The filing reports only this grant transaction and does not show any share sales or option exercises.

Insider Trade Summary

Grant/Award: 11,436 shares

Grant/Award 1 txn

Insider Hughes Bryan W

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,436	$0.00	$0.00

Holdings After Transaction: Common Stock — 32,663 shares (Direct)

Footnotes (1)

1. F1. Includes restricted stock awards totaling 17,959 shares.

Key Figures

Stock award: 11,436 shares Grant price: $0.0000 per share Total holdings after: 32,663 shares +1 more

4 metrics

Stock award 11,436 shares Common Stock grant to director on 2026-06-09

Grant price $0.0000 per share Equity compensation, not an open-market purchase

Total holdings after 32,663 shares Direct ownership following the reported grant

Restricted stock included 17,959 shares Restricted stock awards within total direct holdings

Key Terms

restricted stock awards, Common Stock, Grant, award, or other acquisition

3 terms

restricted stock awards financial

"Includes restricted stock awards totaling 17,959 shares."

Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.

Common Stock financial

"security_title: "Common Stock" for the reported transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did OrthoPediatrics (KIDS) report for director Bryan W. Hughes?

OrthoPediatrics reported an equity grant to director Bryan W. Hughes. He received 11,436 shares of common stock as a stock award, with no cash paid per share, reflecting compensation rather than a market purchase or sale of existing holdings.

How many OrthoPediatrics (KIDS) shares did Bryan W. Hughes receive and at what price?

Bryan W. Hughes received 11,436 shares of OrthoPediatrics common stock in a Form 4-reported award. The transaction price per share was listed as $0.0000, indicating a grant of shares as compensation instead of an open-market purchase at a stated trading price.

What are Bryan W. Hughes’ total OrthoPediatrics (KIDS) holdings after this Form 4 transaction?

After the grant, Hughes directly holds 32,663 shares of OrthoPediatrics common stock. This total includes previously held shares plus the 11,436-share award reported in the filing, and encompasses restricted stock awards that form part of his overall equity position.

How many restricted OrthoPediatrics (KIDS) shares does Bryan W. Hughes hold?

The footnote states Hughes holds 17,959 restricted shares within his total ownership. These restricted stock awards are part of his 32,663-share direct position and typically are subject to vesting or service-based conditions as part of long-term incentive compensation.

Did the OrthoPediatrics (KIDS) Form 4 show any stock sales by Bryan W. Hughes?

No stock sales were reported in this Form 4 for Bryan W. Hughes. The filing shows only an acquisition coded as a grant or award, with 11,436 shares added to his holdings and no dispositions, exercises, or tax-withholding transactions listed.

Was the OrthoPediatrics (KIDS) Form 4 transaction an open-market buy by the director?

The transaction was not an open-market purchase. It is coded as an “A” transaction, described as a grant, award, or other acquisition, with a $0.0000 per-share price, indicating a stock award provided as compensation rather than a voluntary market buy.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/10/2026 - 09:49 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hughes Bryan W

(Last) (First) (Middle)

C/O ORTHOPEDIATRICS CORP.

2850 FRONTIER DRIVE

(Street)

WARSAW INDIANA 46582

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/09/2026		A		11,436	A	$0	32,663(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes restricted stock awards totaling 17,959 shares.

Remarks:

	/s/ Daniel J. Gerritzen, Attorney-in-Fact	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)